Plug and Play

Plug and Play, founded in 2006 and based in Sunnyvale, California, operates as a business accelerator and venture capital firm that focuses on early-stage and seed investments in technology startups. The firm runs 12 industry-specific accelerator programs annually, connecting startups with corporate partners and investors to foster collaboration and growth. Plug and Play's investment strategy encompasses a wide range of sectors, including fintech, health and wellness, travel, cybersecurity, and sustainability, allowing it to support diverse startups from any country. The firm provides various resources, including funding, mentorship, office space, and networking opportunities, and has a global presence with offices in North America, Europe, and Asia. Plug and Play has a strong track record, having helped numerous startups secure over $9 billion in funding since its inception. Its programs aim to refine business models and facilitate introductions to potential investors, ultimately contributing to the growth of the startup ecosystem.

Saeed Amidi

Co-Founder & Co-Chief Executive Officer

Kiswana Browne

Associate

Gabriela Dow

Co-Founder and Partner

Matt Helmers

Director of Strategy and Innovation

Alex Roudi

Managing Partner, San Diego

Marc Steiner

General Counsel

Jupe Tan

Managing Partner, Asia Pacific & Senior Vice President, Global Operations

Phillip Vincent

Managing Partner, East Asia

Chen Zhao

Managing Partner, China

Past deals in Health Diagnostics

Syndi Health

Pre Seed Round in 2023
Outcome-driven digital health support recommendation platform using machine learning and digital phenotyping - starting in mental health.

Syndi Health

Seed Round in 2022
Outcome-driven digital health support recommendation platform using machine learning and digital phenotyping - starting in mental health.

Redi.Health

Seed Round in 2021
Redi.Health is a healthcare technology company that develops health management platforms for patients. The company aims to connect patients with chronic diseases to patient support programs. These programs are created in partnership with pharmaceutical manufacturers and are always free to the patient.

LingoHealth

Pre Seed Round in 2021
LingoHealth is a digital health platform designed to assist family members in supporting the health of their aging loved ones, particularly focusing on multilingual families. Recognizing that multilingual caregivers are significantly more involved in caregiving than their English-fluent counterparts, LingoHealth offers tools that enhance visibility into the necessary steps for appropriate care. The platform enables families to navigate healthcare options effectively and ensures that immigrant patients receive support in their preferred language and cultural context. By doing so, LingoHealth aims to improve engagement in care and promote better health management for seniors.

Live Chair

Convertible Note in 2021
Live Chair offers an app that encourages and inspires barbers and their clients to become more aware of their health, catching signs of heart issues by checking their blood pressure, and discussing other potential issues. This requires no extra cost and no extra time for the clients, many of whom have likely not seen a doctor in years. By equipping barbers with tools for checking blood pressure, BMI, and HRA, Live Chair Health is championing an assertive strategy to support African-American men’s long-term health.

Gabbi

Convertible Note in 2021
Gabbi is a healthcare software provider focused on empowering women to take control of their health. The platform enables women to understand their bodies better, facilitating awareness of what is normal for them, which is crucial for recognizing abnormalities. Gabbi offers a risk calculator for breast cancer identification and provides virtual chat, community support, and video appointments, fostering a supportive environment for women facing health challenges. By connecting like-minded individuals and assisting health systems in meeting quality measures, Gabbi aims to enhance health outcomes for women and promote proactive health management.

ixlayer

Series A in 2021
ixlayer enables leading health systems, clinical labs, biopharma, and consumer companies to offer precision health testing, by remove all the technical, security, and regulatory complexity involved in launching a clinical health test.

Liquid Mine

Seed Round in 2021
Liquid Mine developed MyRD which uses the diagnostic test tailored by the way of liquid biopsy and gene analysis of individuals. MyRD system can identify how many leukemia cell is decreased or still being left and developing recurrence in a body in more accurate manner.

Sensill

Seed Round in 2021
Sensill revolutionizes point-of-care noninvasive skin diagnostics.

Kit

Seed Round in 2021
Kit specializes in at-home health testing solutions, providing comprehensive kits that enable organizations to offer a safe and convenient alternative to traditional doctor and laboratory visits. By making preventative health testing accessible across various industries, Kit facilitates reliable health monitoring for customers, ensuring ease of use and enhanced accessibility. The company aims to streamline the health testing process, allowing individuals to manage their health from the comfort of their homes while supporting organizations in delivering effective health services.

Kit

Seed Round in 2020
Kit specializes in at-home health testing solutions, providing comprehensive kits that enable organizations to offer a safe and convenient alternative to traditional doctor and laboratory visits. By making preventative health testing accessible across various industries, Kit facilitates reliable health monitoring for customers, ensuring ease of use and enhanced accessibility. The company aims to streamline the health testing process, allowing individuals to manage their health from the comfort of their homes while supporting organizations in delivering effective health services.

Predictiv

Convertible Note in 2020
Predictiv provides a personal genomics solution for predictive medicine. The company aims to prevent or decrease the impact of disease upon the patient. By predicting the probability of disease, preventive measures can be instituted.

Helium Health

Series A in 2020
Helium Health is a technology company focused on transforming healthcare in Africa through its electronic health records and hospital management systems. Founded in 2016 and headquartered in Lagos, Nigeria, the company provides a comprehensive suite of software tools designed to digitize medical records, manage hospital operations, and facilitate financial applications. Its platform features capabilities for managing patient visits, prescriptions, billing, and telemedicine solutions, all accessible from various devices. Additionally, Helium Health offers functionalities such as customizable forms, smart analytics, appointment management, and alerts, which help healthcare providers enhance efficiency, improve patient care, and reduce operational waste. By leveraging technology, Helium Health aspires to become the leading healthcare data exchange in Africa.

Bloomlife

Series A in 2020
Bloomlife is a women’s health company solving the most significant yet underserved global challenges today in maternal health. We combine connected devices with data analytics to increase access to care, provide personalized feedback to moms, and help doctors earlier predict and manage pregnancy complications. At the center of our solution is a prenatal wearable that tracks critical health parameters of maternal and fetal health. By addressing modifiable risk factors, detecting abnormalities, and predicting adverse events Bloomlife aims to ensure every family gets a healthy start.

Healthlane

Convertible Note in 2020
Healthlane is a healthcare technology company that operates an online application aimed at enhancing access to quality and affordable healthcare services in Africa. Established in 2020 and headquartered in Lagos, Nigeria, with additional offices in Yaounde, Cameroon, and San Francisco, California, the platform facilitates users in tracking medical appointments and consolidating their health data. It offers features such as virtual medical advice on various health topics, including pregnancy, vaccinations, lab results, family planning, and insurance records. By enabling direct communication with certified doctors, Healthlane empowers individuals to make informed health decisions and efficiently monitor their health status.

Bold Health

Convertible Note in 2020
Bold Health is a digital therapeutic platform that leverages evidence-based cognitive behavioural​ and stress reduction therapies to help patients with Digestive Health conditions​ to ​better manage and treat their physical and mental health. The company's first product is called Zemedy, the world's first integrative digital therapeutic app for Irritable Bowel Syndrome.

TestCard

Venture Round in 2019
TestCard Diagnostics Ltd, operating as TestCard.com, is a health technology company that specializes in at-home medical testing solutions. Founded in 2017 by Dr. Andrew Botham and Luke Heron, the company has developed an innovative pull-out urine test kit that integrates with a mobile application, allowing users to receive immediate results. The urinalysis system combines the precision of medical lab tests with mobile technology, enabling users to apply urine to a test strip embedded in a postcard and scan it with their smartphone to obtain clinical-grade results. TestCard's technology is designed for privacy and convenience, allowing individuals to diagnose and monitor common health conditions at home. The company has received approvals for its medical devices in 27 countries for detecting urinary tract infections and is expanding its product range to include tests for pregnancy, ovulation optimization, and diabetes management. Based in London, TestCard is at the forefront of the shift towards preventative healthcare solutions.

Visby Medical

Series C in 2019
Visby Medical is a diagnostics company that develops PCR-based diagnostic tests for the detection of infectious diseases. The company develops a device platform that aims to redefine the way an illness is tested and treated. They believe that by taking a human-centric, technology-first approach to device development and they can create tools that are both highly accurate and delightful to use.

Gali Health

Seed Round in 2018
Gali Health, Inc. is a health technology company based in San Francisco, California, established in 2015. The company focuses on developing a mobile application named Gali, which serves as a personal health assistant designed to support individuals with chronic conditions. By leveraging collective intelligence, Gali enables users to proactively manage their health through crowdsourced personal health data and medically-validated insights. The application employs artificial intelligence to provide highly personalized support, addressing medical, lifestyle, and psychological aspects of living with chronic diseases. Gali Health aims to empower users by ensuring they do not feel isolated or powerless in managing their health, advancing consumer-driven healthcare through innovative technology and personalized health tracking.

Guardant Health

Venture Round in 2018
Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and rare-cell diagnostics and is closely advised by an oncologist-led medical steering committee from leading cancer centers across North America and abroad.

Flux Bioscience

Seed Round in 2018
Flux Bioscience is a company that originated from Stanford University, focusing on developing a portable biosensor platform that allows for sensitive and quantitative point-of-care in vitro medical diagnostics. By repurposing technology initially designed for computer hard drives, Flux Bioscience's platform measures biomarkers in blood, urine, or saliva related to exercise, stress, fertility, and diet. The biosensor employs biochips equipped with sensors to detect specific biomarkers, facilitating the simultaneous measurement of multiple biomarkers within each sample. This technology enables real-time detection of magnetic nanoparticles through antibody-antigen interactions, providing users with accessible, affordable, and actionable health insights. By correlating these biomarker measurements with data from wearable technologies related to sleep and activity, Flux Bioscience empowers individuals to take control of their healthcare and lifestyle decisions.

ixlayer

Seed Round in 2018
ixlayer enables leading health systems, clinical labs, biopharma, and consumer companies to offer precision health testing, by remove all the technical, security, and regulatory complexity involved in launching a clinical health test.

Heal

Convertible Note in 2018
Heal brings technology innovation to re-humanize the practice of medicine in a way that is fulfilling for doctors and patients alike. Heal brings a licensed, background-checked pediatrician or family doctor to you, on-demand, on your schedule, for $99 or for an in-network co-pay with select insurance plans. Great doctors are available in Los Angeles, Orange County, San Francisco, Silicon Valley and San Diego from 8am to 8pm, seven days a week.

Visby Medical

Debt Financing in 2018
Visby Medical is a diagnostics company that develops PCR-based diagnostic tests for the detection of infectious diseases. The company develops a device platform that aims to redefine the way an illness is tested and treated. They believe that by taking a human-centric, technology-first approach to device development and they can create tools that are both highly accurate and delightful to use.

Chiron Health

Seed Round in 2017
Chiron Health, Inc. is a web-based platform that facilitates secure video conferencing between physicians and patients, primarily for routine follow-up appointments. Founded in 2013 and based in Austin, Texas, the company focuses on enhancing telemedicine for primary care, behavioral health, and other specialties. Chiron Health uniquely enables physician practices to receive reimbursement for video consultations, converting previously unpaid follow-up calls into billable telemedicine encounters. By addressing the complexities of state medical board compliance and HIPAA regulations, Chiron Health provides a comprehensive solution that allows practices to navigate the challenging reimbursement landscape. Additionally, the platform includes a proprietary database to verify patients' insurance eligibility for telemedicine services. As a result, Chiron Health presents an economically viable telemedicine option that supports practices in generating significant additional revenue. The company operates as a subsidiary of Medici Technologies, LLC, and has established itself as a leader in the outpatient telemedicine sector.

Bloomlife

Series A in 2017
Bloomlife is a women’s health company solving the most significant yet underserved global challenges today in maternal health. We combine connected devices with data analytics to increase access to care, provide personalized feedback to moms, and help doctors earlier predict and manage pregnancy complications. At the center of our solution is a prenatal wearable that tracks critical health parameters of maternal and fetal health. By addressing modifiable risk factors, detecting abnormalities, and predicting adverse events Bloomlife aims to ensure every family gets a healthy start.

Dynosense

Series B in 2017
DynoSense Corp. manufactures integrated multi-function health scanner technology that captures health data. The company was founded in 2013 and is based in Sunnyvale, California.

Multerra Bio

Seed Round in 2017
MULTERRA BIO, INC. develops a handheld device for performing various diagnostics with a single and consumable cartridge. The company was incorporated in 2015 and is based in San Francisco, California.

Health Gorilla

Seed Round in 2016
Health Gorilla, Inc. specializes in providing interoperability solutions that enhance data sharing across the healthcare ecosystem, including patients, payers, providers, digital health solutions, and laboratories. The company's main offering is a clinical network that aggregates and normalizes patient data, facilitates clinical orders, and delivers real-time notifications, empowering patients with access to their personal health information. By ensuring secure interoperability and supporting social determinants of health (SDOH), Health Gorilla aims to deliver high-quality, actionable data that improves healthcare delivery, clinical outcomes, and revenue cycle management for healthcare organizations. The company, originally founded as Informedika, Inc. in 2011, rebranded to Health Gorilla in April 2014 and is headquartered in Sunnyvale, California.

HealAI

Seed Round in 2016
Beijing Wanling Pangu Technology Co., Ltd. provides integrated services for mental diagnostics and treatment based on precision medicine and artificial intelligence. It also designs and develops health care application such as heart mirror app, and cardiac doctor app. The company's products include enterprise psychological services, child brain development screening, and cardiac pre-diagnosis system. The company was founded in 2016 and is based in Beijing, China.

Bloomlife

Seed Round in 2016
Bloomlife is a women’s health company solving the most significant yet underserved global challenges today in maternal health. We combine connected devices with data analytics to increase access to care, provide personalized feedback to moms, and help doctors earlier predict and manage pregnancy complications. At the center of our solution is a prenatal wearable that tracks critical health parameters of maternal and fetal health. By addressing modifiable risk factors, detecting abnormalities, and predicting adverse events Bloomlife aims to ensure every family gets a healthy start.

Precision Wellness

Seed Round in 2016
The Harris Center for Precision Wellness, located within the Icahn Institute for Genomics and Multiscale Biology, embodies a new paradigm in health and medicine. The Center’s goal is to establish a solid foundation for the realization of Precision Wellness, a highly-personalized and proactive approach for maintaining optimal health and vitality and preventing disease. Towards this goal, the center will harness the recent advances in digital health, genomics, and data science to bring us bringing precision medicine by revealing how individual differences in genes, environments, and lifestyles contribute to complex human diseases, and how to apply these potent technologies to help preserve and enhance wellness.

Dynosense

Series A in 2015
DynoSense Corp. manufactures integrated multi-function health scanner technology that captures health data. The company was founded in 2013 and is based in Sunnyvale, California.

BaseHealth

Series B in 2015
BaseHealth, Inc. is a health management platform designed for physicians and their patients, integrating genomic, medical, behavioral, and environmental data to evaluate disease risks. The platform aids physicians in formulating personalized action plans aimed at disease prevention. It serves as a clinical support tool, enhancing medical decision-making by combining physician expertise, clinical knowledge, genome interpretation, and health analytics. Additionally, BaseHealth provides tailored recommendations regarding diet and physical activity based on individual health conditions and genetic profiles. Founded in 2008, the company is headquartered in Sunnyvale, California, and operates as a subsidiary of Genalyte, Inc. The platform employs machine learning to analyze extensive medical literature and patient records, enabling healthcare providers to identify patients at risk for 43 chronic diseases, ultimately aiming to reduce the need for costly treatments.

Statim Health

Seed Round in 2014
Statim Health is a free digital platform that enables healthcare pricing transparency.

Guardant Health

Convertible Note in 2012
Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and rare-cell diagnostics and is closely advised by an oncologist-led medical steering committee from leading cancer centers across North America and abroad.

BaseHealth

Series A in 2011
BaseHealth, Inc. is a health management platform designed for physicians and their patients, integrating genomic, medical, behavioral, and environmental data to evaluate disease risks. The platform aids physicians in formulating personalized action plans aimed at disease prevention. It serves as a clinical support tool, enhancing medical decision-making by combining physician expertise, clinical knowledge, genome interpretation, and health analytics. Additionally, BaseHealth provides tailored recommendations regarding diet and physical activity based on individual health conditions and genetic profiles. Founded in 2008, the company is headquartered in Sunnyvale, California, and operates as a subsidiary of Genalyte, Inc. The platform employs machine learning to analyze extensive medical literature and patient records, enabling healthcare providers to identify patients at risk for 43 chronic diseases, ultimately aiming to reduce the need for costly treatments.